Skip to main content

Interleukin-1 Production by Mononuclear Cells and Natural Killer Cell Activity in Children with Acute Lymphoblastic Leukemia

  • Conference paper
Book cover Acute Leukemias

Abstract

Interleukin 1 (IL-1) plays a major role in the response to infection, in inflammation, and in every immunological challenge. Over the past 10 years a variety of additional activities, especially of purified IL-1 on various target cells in vitro, has been reported [1]. As shown by Shirakawa et al. [2], IL-1 enhances also natural killer (NK) cell cytotoxic effect and proliferation. Expression of IL-2 receptors on NK cell surface can be regulated by IL-1 [3]. [4] Although IL-1 acts directly on many immunocompetent cells its role in malignant diseases has not yet been extensively explored [5]. We have previously reported apparent deficiency of IL-1 production by mononuclear cells of children with acute lymphoblastic leukemia (ALL) during the whole period of cytostatic therapy [6].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fibbe E, Schaafsma MR, Falkenburg FJ, Willmze R (1989) The biological activities of interleukin 1. Blut 59: 177

    Article  Google Scholar 

  2. Shirakawa F, Tanaka Y, Eto S, Suzuki H, Yodo Y, Yamashita U (1986) Effect of interleukin 1 on the expression of interleukin 2 receptor (TAC antigen) on human natural killer cells and natural killer-like cell line (YT cells). J Immunol 137: 551

    PubMed  CAS  Google Scholar 

  3. Kataoka Y, Todo S, Morioka Y, Sugie K, Nakamura Y, Yodoi J, Imashuku S (1990) Impaired natural killer activity and expression of interleukin 2 receptor antigen in familial erythophagocytic lymphohistiocytosis. Cancer 65: 1937

    Article  PubMed  CAS  Google Scholar 

  4. Peppoloni S, Bossu P, Boraschi D, Tagliabue A (1989) A short synthetic peptide fragment of human interleukin 113 increases both human and murine natural killer activity. Nat Immun Cell Growth Regul 8: 10–19

    PubMed  CAS  Google Scholar 

  5. Herman JA, Kew MC, Rabson AR (1984) Defective interleukin-1 production by monocytes from patients with malignant diseases: interferon increasas IL-1 production. Cancer Immunol Immunother 16: 182–185

    Article  PubMed  CAS  Google Scholar 

  6. Chybicka A, Boguslawska-Jaworska J (1990) Interleukin 1 production in childhood acute lymphoblastic leukemia during chemo-and radiotherapy according to BFM (BerlinFrankfurt-Munster) protocol. In: Büchner T et al. Acute leukemias II. Berlin Heidelberg New York 33: 72 (Hematology and blood transfusion)

    Google Scholar 

  7. Frydecka I (1985) Natural killer cell activity during the course of disease in patients with Hodgkin’s disease. Cancer 56: 2799

    Article  PubMed  CAS  Google Scholar 

  8. Pross HF, Maroun JA (1984) The standardisation of NK cell assays for use in studies of biological response modifiers. J Immunol Methods 68: 235

    Article  PubMed  CAS  Google Scholar 

  9. Zimecki M, Wieczorek Z (1987) IL-1 decreases the level of thymocytes forming rosettes with autologous erythrocytes, a new method of determination of I1–1 activity. Arch Immunol Ther Exp (Warsz) 355: 371

    Google Scholar 

  10. Migliorati G, Cannarile L, D’Adamio L, Herberman RB, Riccardi C (1987) Interleukin 1 auguments the interleukin 2 dependent generation of natural killer cells from bone marrow precursor. Nat Immun Cell Growth Regul 6: 306

    PubMed  CAS  Google Scholar 

  11. Pross HF, Baines M (1987) Alterations in natural killer cell activity in tumor-bearing hosts. In: Herberman RB, et al. (eds) Immune responses to metastases. CRC Press, Boca Raton, p 57

    Google Scholar 

  12. Lange A, Flad HD, Jack A, Ulmer AJ (1986) Effect of human recombinant interleukin 2 on natural killing of low density percoll fraction cells. Immunol Lett 12: 243–250

    Article  PubMed  CAS  Google Scholar 

  13. Douer D, Shaked N, Ramot B (1987) Normal natural killer activity in Hodgkin’s disease patients in remission. Clin exp Immunol 69: 660–667

    PubMed  CAS  Google Scholar 

  14. Mehta BA, Satam MN, Advani H, Nadkarin JJ (1989) In vitro modulation of natural killer cell activity in non-Hodgkin’s lymphoma patients after therapy. Cancer Immunol Immunother 28: 148–152

    Article  PubMed  CAS  Google Scholar 

  15. Tanaka Y (1981) Natural killer NK activity in children with acute lymphoblastic leukemia. Hiroshima J Med Sci 30: 127

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Chybicka, A., Boguslawska-Jaworska, J., Budzyński, W., Radzikowski, C., Jaworski, W. (1992). Interleukin-1 Production by Mononuclear Cells and Natural Killer Cell Activity in Children with Acute Lymphoblastic Leukemia. In: Hiddemann, W., Büchner, T., Wörmann, B., Plunkett, W., Keating, M., Andreeff, M. (eds) Acute Leukemias. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 34. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76591-9_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76591-9_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-53949-0

  • Online ISBN: 978-3-642-76591-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics